Sierra Capital’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
Sierra Capital's PCRX Position: Q3 2026 in Review
Sierra Capital held its Pacira BioSciences (PCRX) position steady in Q3 2026 at 12,500 shares worth $313K. The position accounts for 0.03% of the portfolio, ranked #189.
Sierra Capital first reported a position in PCRX in Q2 2025 and has held it in 6 quarters since. The position peaked at $324K in Q4 2025. 257 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.
- Sierra Capital held 12,500 shares of Pacira BioSciences worth $313K as of Q3 2026.
- Sierra Capital left its Pacira BioSciences share count unchanged in Q3 2026.
- Pacira BioSciences made up 0.03% of Sierra Capital's portfolio in Q3 2026, its #189 holding.
- Sierra Capital first reported a position in Pacira BioSciences in Q2 2025 and has held it in 6 quarters since.
- Sierra Capital's Pacira BioSciences position peaked at $324K in Q4 2025.
- 257 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.
Based on Sierra Capital's 13F filing for Q3 2026, filed 16 Nov 2026.